Collector
Are counterfeit cancer drugs entering India before patent expiry? Keytruda raises safety concerns | Collector
Are counterfeit cancer drugs entering India before patent expiry? Keytruda raises safety concerns
Business Today

Are counterfeit cancer drugs entering India before patent expiry? Keytruda raises safety concerns

Developed by Merck & Co., Keytruda is used across cancers including lung cancer, melanoma, and head and neck cancers

Go to News Site